<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806014/" ref="ordinalpos=893&amp;ncbi_uid=2200461&amp;link_uid=PMC2806014" image-link="/pmc/articles/PMC2806014/figure/F1/" class="imagepopup">Figure 1.The TOR intracellular <span class="highlight" style="background-color:">signaling</span> <span class="highlight" style="background-color:">pathway</span>..  From: Validation of anti-aging drugs by treating age-related diseases. </a></div><br /><div class="p4l_captionBody"> Nutrients, GF (growth factors)                                             and insulin activate the TOR pathway, which is involved in aging and                                             age-related diseases. Other genetic factors and environmental factors                                             (e.g., smoking) contribute to specific age-related diseases. Three                                             potential anti-aging modalities (metformin, calorie restriction and                                             rapamycin) all inhibit the TOR pathway.                                                              </div></div>